Worldnews Rules

India has approved the sale of generic versions of hepatitis C drugs. The move will bring down the standard course of sofosbuvir and ledipasvir (generic versions of Sovaldi and Harvoni) to $1000 compared to $90,000 in United states and Europe. (digitaljournal.com) via Pocket http://ift.tt/1XoLC4D